Analyst Reco. Revvity, Inc.

Equities

RVTY

US7140461093

Market Closed - Nyse Other stock markets 04:00:01 2024-06-11 pm EDT			5-day change	1st Jan Change
109.7 ^USD	+0.37%		+1.08%	+0.36%

Jun. 10	Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
May. 14	Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Adjusts Price Target on Revvity to $130 From $123	Apr. 30	MT
JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	Apr. 30	MT
Baird Adjusts Price Target on Revvity to $127 From $126	Apr. 30	MT
Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating	Apr. 30	MT
Nephron Adjusts Revvity's Price Target to $124 From $120	Apr. 29	MT
Bernstein Adjusts Price Target on Revvity to $125 From $126	Apr. 22	MT
Baird Adjusts Price Target on Revvity to $126 From $123	Apr. 22	MT
KeyBanc Ups Price Target on Revvity to $126 From $110, Keeps Overweight Rating	Feb. 02	MT
Raymond James Raises Price Target on Revvity to $127 From $106, Maintains Outperform Rating	Feb. 02	MT
Job data is good for the economy, not for rate cuts	Feb. 02
ANALYST RECOMMENDATIONS : Alphabet, Meta Platforms, Amazon, Wise, Clorox...	Feb. 02
BofA Securities Raises Price Target on Revvity to $117 From $104, Maintains Neutral Rating	Jan. 29	MT
Barclays Adjusts Price Target on Revvity to $105 From $92, Maintains Equal-Weight Rating	Jan. 25	MT
UBS Downgrades Revvity to Neutral From Buy, Raises Price Target to $125 From $105	Jan. 16	MT
Evercore ISI Upgrades Revvity to Outperform From In-Line, Raises Price Target to $125 From $88	Jan. 04	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
Wells Fargo Starts Revvity With Equalweight Rating, $95 Price Target	Dec. 19	MT
BofA Securities Adjusts Price Target on Revvity to $104 From $103, Maintains Neutral Rating	Dec. 12	MT
Raymond James Cuts Revvity's Price Target to $106 From $135, Maintains Outperform Rating	23-10-31	MT
UBS Adjusts Revvity Price Target to $105 From $160, Maintains Buy Rating	23-10-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Revvity, Inc.

Equities

RVTY

US7140461093

Analyst Reco.

Filters